
Corporate Action13 Oct 2026, 07:20 pm
Krsnaa Diagnostics Allots 16.21 Lakh Warrants to Promoters
AI Summary
Krsnaa Diagnostics Ltd has allotted 16,21,000 fully convertible warrants on a preferential basis to promoter entities, Mr. Rajendra Mutha and Krsna Diagnostics (Mumbai) Private Limited. The allotment follows board and shareholder approvals and in-principle approvals from BSE and NSE. The warrants were issued at a price of ₹566 per warrant, with 25% of the subscription price aggregating to ₹22,93,71,500 received upfront. These warrants are convertible into equity shares within 18 months. The company's paid-up share capital remains unchanged at this stage.
Key Highlights
- 16.21 lakh warrants allotted to promoter group entities.
- Warrants issued on preferential basis at ₹566 per warrant.
- ₹22.94 Crore received as 25% upfront payment.
- Conversion into equity shares possible within 18 months.
- No immediate change in paid-up share capital.
Price Impact
More from KRSNAA